Evidence map›Paper›PMID 41530496›Full record

ArticleCommunications biology2026

Fetal reversion from diverse lineages sustains the intestinal stem cell pool and confers stress resilience.

Sakura Kirino, Fumiya Uefune, Kensuke Miyake, Nobuhiko Ogasawara, Sakurako Kobayashi, Satoshi Watanabe, Yui Hiraguri, Go Ito, Keiichi Akahoshi, Daisuke Ban and 5 more

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Early-life colonization withScience (New York, N.Y.) · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sakura KirinoDepartment of Gastroenterology and Hepatology, Institute of Science Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0001-5921-9654
Fumiya UefuneCenter for Stem Cell and Regenerative Medicine, Institute of Biomedical Engineering, Institute of Science Tokyo, Tokyo, Japan.
Kensuke MiyakeInstitute of Integrated Research, Institute of Science Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-1149-3755
Nobuhiko OgasawaraDepartment of Gastroenterology and Hepatology, Institute of Science Tokyo, Tokyo, Japan.
Sakurako KobayashiDepartment of Gastroenterology and Hepatology, Institute of Science Tokyo, Tokyo, Japan.
Satoshi WatanabeDepartment of Gastroenterology and Hepatology, Institute of Science Tokyo, Tokyo, Japan.
Yui HiraguriDepartment of Gastroenterology and Hepatology, Institute of Science Tokyo, Tokyo, Japan.
Go ItoDepartment of Gastroenterology and Hepatology, Institute of Science Tokyo, Tokyo, Japan.ORCID http://orcid.org/0009-0004-7488-0335
Keiichi AkahoshiDepartment of Hepatobiliary and Pancreatic Surgery, Institute of Science Tokyo, Tokyo, Japan.
Daisuke BanDepartment of Hepatobiliary and Pancreatic Surgery, Institute of Science Tokyo, Tokyo, Japan.
Johan H van EsOncode, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), University Medical Center (UMC), Utrecht, the Netherlands.
Hans CleversOncode, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), University Medical Center (UMC), Utrecht, the Netherlands.ORCID http://orcid.org/0000-0002-3077-5582
Mamoru WatanabeOrganoid Center, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Ryuichi OkamotoDepartment of Gastroenterology and Hepatology, Institute of Science Tokyo, Tokyo, Japan. rokamoto.gast@tmd.ac.jp.ORCID http://orcid.org/0000-0002-7047-571X
Shiro YuiCenter for Stem Cell and Regenerative Medicine, Institute of Biomedical Engineering, Institute of Science Tokyo, Tokyo, Japan. yui.arm@tmd.ac.jp.ORCID http://orcid.org/0000-0003-4268-647X

Funding

MEXT | Japan Science and Technology Agency (JST) JPMJFR2012MEXT | Japan Science and Technology Agency (JST) JPMJSP2120MEXT | Japan Science and Technology Agency (JST) JPMJSP2180MEXT | Japan Society for the Promotion of Science (JSPS) 22H00472MEXT | Japan Society for the Promotion of Science (JSPS) 23H02887
6 · The paper itself

Abstract

Plasticity is a central mechanism underlying the robust regenerative capacity of the intestinal epithelium. Two major forms of plasticity have been described: spatial plasticity, in which differentiated cells revert to crypt base columnar cells (CBCs), and fetal reversion into revival stem cells (revSCs). However, the relationship among these two stem cell populations and differentiated cells remains to be clarified. Here, we demonstrated the bidirectional interconversion between CBCs and revSCs. Using lineage tracing, injury models and villus culture, we show that absorptive enterocytes can reprogram into revSCs and regenerate CBCs. These findings position fetal reversion as an entry point to spatial plasticity, establishing a regenerative hierarchy where CBCs, revSCs, and enterocytes collectively orchestrate intestinal repair. Furthermore, we identified revSCs as a highly stress-tolerant stem cell population, whose emergence would preserve the stem cell pool. Our results establish fetal reversion as a cellular escape mechanism safeguarding epithelial regeneration under inflammatory conditions.

Indexed as

Cell LineageIntestinal MucosaStem CellsStress, PhysiologicalAnimalsCell DifferentiationEnterocytesMiceRegeneration

Identifiers

PMID41530496
PMCPMC12909903

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.